Ruibo (Suzhou) Pharmaceutical Co., Ltd. announced that it has received CNY 560,000,000 in a round of funding on April 27, 2023. The transaction included participation from returning investor, Zhejiang Jiuzhou Pharmaceutical Co., Ltd. The transaction has been approved in the 29th meeting of the 7th directorate and the 22nd meeting of the 7th supervisory board of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Recently, the company has completed the change of business registration of its capital increase.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.6 CNY | +3.24% | +5.62% | -35.56% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-35.56% | 1.88B | |
+25.83% | 653B | |
+27.00% | 556B | |
-6.76% | 354B | |
+20.34% | 331B | |
+3.00% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-6.26% | 144B |
- Stock Market
- Equities
- 603456 Stock
- News Zhejiang Jiuzhou Pharmaceutical Co., Ltd
- Ruibo Pharmaceutical Co., Ltd. announced that it has received CNY 560 million in funding from Zhejiang Jiuzhou Pharmaceutical Co., Ltd